https://scholars.lib.ntu.edu.tw/handle/123456789/564584
標題: | LC3 overexpression reduces Aβ neurotoxicity through increasing α7nAchR expression and autophagic activity in neurons and mice | 作者: | Hung S.-Y. Huang W.-P. Liou H.-C. WEN-MEI FU |
公開日期: | 2015 | 卷: | 93 | 起(迄)頁: | 243-251 | 來源出版物: | Neuropharmacology | 摘要: | Autophagy is an intracellular degradation pathway with dynamic interactions for eliminating damaged organelles and protein aggregates by lysosomal digestion. The EGFP-conjugated microtubule-associated protein 1 light chain 3 (EGFP-LC3) serves to monitor autophagic process. Extracellular β-amyloid peptide accumulation is reported as a major cause in Alzheimer's disease (AD) pathogenesis; large numbers of autophagic vacuoles accumulate in patients' brains. We previously demonstrated that extracellular Aβ (eAβ) induces strong autophagic response and α7nAChR acts as a carrier to bind with eAβ; which further inhibits Aβ-induced neurotoxicity via autophagic degradation. In the present study, we overexpressed LC3 in both neuroblastoma cells (SH-SY5Y/pEGFP-LC3) and mice (TgEGFP-LC3) to assess the effect of LC3 overexpression on Aβ neurotoxicity. SH-SY5Y/pEGFP-LC3 cells and primary cortical neuron cultures derived from E17 (embryonic day 17) TgEGFP-LC3 mice showed not only better resistance against Aβ neurotoxicity but also higher α7nAChR expression and autophagic activity than control. Administration of α-bungarotoxin (α-BTX) to block α7nAChR antagonized the neuroprotective action of SH-SY5Y/pECGF-LC3 cells, suggesting that eAβ binding with α7nAChR is an important step in Aβ detoxification. LC3 overexpression thus exerts neuroprotection through increasing α7nAChR expression for eAβ binding and further enhancing autophagic activity for Aβ clearance in vitro and in vivo. ? 2015 Elsevier Ltd. All rights reserved. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/564584 | ISSN: | 283908 | DOI: | 10.1016/j.neuropharm.2015.02.003 | SDG/關鍵字: | alpha bungarotoxin; amyloid beta protein; amyloid beta protein[1-42]; amyloid beta protein[25-35]; bungarotoxin receptor; membrane protein; microtubule associated protein 1 light chain 3; unclassified drug; actin; amyloid beta protein; amyloid beta-protein (1-42); amyloid beta-protein (25-35); bungarotoxin; bungarotoxin receptor; caspase 3; MAP1LC3 protein, mouse; microtubule associated protein; nicotinic receptor blocking agent; peptide fragment; animal cell; animal tissue; apoptosis; Article; autophagy; controlled study; disease resistance; embryo; gene overexpression; in vitro study; in vivo study; mouse; nerve cell; nerve cell culture; neuroprotection; neurotoxicity; nonhuman; priority journal; protein expression; protein protein interaction; animal; animal embryo; autophagy; brain cortex; cell culture; cytology; dose response; drug effects; gene expression regulation; genetics; human; metabolism; nerve cell; neuroblastoma; pathology; transgenic mouse; Actins; alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Autophagy; Bungarotoxins; Caspase 3; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Embryo, Mammalian; Gene Expression Regulation; Humans; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Neuroblastoma; Neurons; Nicotinic Antagonists; Peptide Fragments |
顯示於: | 藥理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。